cBrain A/S Logo

cBrain A/S

CBRAIN.CO

(4.0)
Stock Price

204,00 DKK

14.35% ROA

50.19% ROE

110.33x PER

Market Cap.

4.234.483.881,00 DKK

58.16% DER

0.1% Yield

25.28% NPM

cBrain A/S Stock Analysis

cBrain A/S Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

cBrain A/S Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (25.22%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

4 Net Profit Growth

With a track record of consistent net profit growth over the past five years, this company presents a compelling investment opportunity due to its strong financial performance.

5 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

6 Dividend Growth

Investors can be encouraged by the company's strong dividend growth over the past five years, highlighting its ability to generate consistent returns and provide an attractive investment opportunity.

7 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

8 DER

The stock has a reasonable amount of debt compared to its ownership (58%), suggesting a balanced financial position and a moderate level of risk.

9 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (2.327) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 PBV

The stock's elevated P/BV ratio (26.48x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

11 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

cBrain A/S Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

cBrain A/S Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

cBrain A/S Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

cBrain A/S Revenue
Year Revenue Growth
2005 8.913.908
2006 14.836.788 39.92%
2007 22.804.168 34.94%
2008 28.008.793 18.58%
2009 33.815.327 17.17%
2010 27.419.585 -23.33%
2011 37.816.733 27.49%
2012 38.983.974 2.99%
2013 43.363.860 10.1%
2014 54.794.896 20.86%
2015 68.679.308 20.22%
2016 71.804.578 4.35%
2017 80.570.182 10.88%
2018 83.473.297 3.48%
2019 96.412.308 13.42%
2020 120.119.607 19.74%
2021 154.662.000 22.33%
2022 187.924.000 17.7%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

cBrain A/S Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

cBrain A/S General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 3.308.335
2006 6.861.901 51.79%
2007 14.780.396 53.57%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 6.339.056 100%
2013 7.017.313 9.67%
2014 8.414.927 16.61%
2015 9.173.379 8.27%
2016 11.717.097 21.71%
2017 15.340.776 23.62%
2018 16.432.244 6.64%
2019 20.107.772 18.28%
2020 19.965.901 -0.71%
2021 19.758.000 -1.05%
2022 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

cBrain A/S EBITDA
Year EBITDA Growth
2005 -877.991
2006 3.863.032 122.73%
2007 -3.974.664 197.19%
2008 6.143.150 164.7%
2009 9.011.616 31.83%
2010 4.039.959 -123.06%
2011 11.194.279 63.91%
2012 9.278.932 -20.64%
2013 11.449.820 18.96%
2014 17.536.406 34.71%
2015 23.706.238 26.03%
2016 19.221.387 -23.33%
2017 17.666.743 -8.8%
2018 14.685.023 -20.3%
2019 26.167.978 43.88%
2020 36.776.728 28.85%
2021 58.954.000 37.62%
2022 68.613.000 14.08%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

cBrain A/S Gross Profit
Year Gross Profit Growth
2005 4.589.626
2006 10.097.090 54.55%
2007 18.966.645 46.76%
2008 22.904.372 17.19%
2009 28.269.425 18.98%
2010 20.963.754 -34.85%
2011 31.156.105 32.71%
2012 38.213.877 18.47%
2013 50.048.993 23.65%
2014 62.292.264 19.65%
2015 76.729.209 18.82%
2016 80.965.198 5.23%
2017 91.178.201 11.2%
2018 95.294.291 4.32%
2019 110.041.979 13.4%
2020 136.880.540 19.61%
2021 173.429.000 21.07%
2022 207.790.000 16.54%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

cBrain A/S Net Profit
Year Net Profit Growth
2005 -1.222.633
2006 4.436.732 127.56%
2007 -4.165.451 206.51%
2008 4.219.844 198.71%
2009 6.678.201 36.81%
2010 2.410.033 -177.1%
2011 6.792.886 64.52%
2012 4.206.690 -61.48%
2013 5.652.350 25.58%
2014 9.065.951 37.65%
2015 12.812.566 29.24%
2016 8.437.653 -51.85%
2017 6.676.989 -26.37%
2018 2.493.384 -167.79%
2019 8.110.045 69.26%
2020 15.536.665 47.8%
2021 31.006.000 49.89%
2022 38.383.000 19.22%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

cBrain A/S Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 1 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 1 0%
2021 2 100%
2022 2 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

cBrain A/S Free Cashflow
Year Free Cashflow Growth
2005 1.887.176
2006 138.056 -1266.96%
2007 1.245.691 88.92%
2008 3.411.586 63.49%
2009 3.460.990 1.43%
2010 -458.028 855.63%
2011 3.452.344 113.27%
2012 2.088.545 -65.3%
2013 1.602.972 -30.29%
2014 3.993.190 59.86%
2015 14.035.224 71.55%
2016 -9.689.287 244.85%
2017 -927.407 -944.77%
2018 -6.317.073 85.32%
2019 12.132.661 152.07%
2020 25.631.871 52.67%
2021 30.654.000 16.38%
2022 -164.131.000 118.68%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

cBrain A/S Operating Cashflow
Year Operating Cashflow Growth
2005 1.887.176
2006 138.056 -1266.96%
2007 1.545.691 91.07%
2008 3.411.586 54.69%
2009 6.202.051 44.99%
2010 6.741.460 8%
2011 9.378.405 28.12%
2012 8.650.635 -8.41%
2013 9.063.595 4.56%
2014 12.421.601 27.03%
2015 23.475.185 47.09%
2016 1.299.337 -1706.7%
2017 11.606.654 88.81%
2018 18.664.872 37.82%
2019 27.407.521 31.9%
2020 43.754.459 37.36%
2021 50.231.000 12.89%
2022 62.312.000 19.39%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

cBrain A/S Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 0 0%
2007 300.000 100%
2008 0 0%
2009 2.741.061 100%
2010 7.199.488 61.93%
2011 5.926.061 -21.49%
2012 6.562.090 9.69%
2013 7.460.623 12.04%
2014 8.428.411 11.48%
2015 9.439.961 10.72%
2016 10.988.624 14.09%
2017 12.534.061 12.33%
2018 24.981.945 49.83%
2019 15.274.860 -63.55%
2020 18.122.588 15.71%
2021 19.577.000 7.43%
2022 226.443.000 91.35%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

cBrain A/S Equity
Year Equity Growth
2005 2.388.132
2006 17.397.714 86.27%
2007 20.214.078 13.93%
2008 23.461.073 13.84%
2009 28.406.722 17.41%
2010 30.512.598 6.9%
2011 37.176.668 17.93%
2012 40.319.371 7.79%
2013 45.195.347 10.79%
2014 53.126.051 14.93%
2015 64.391.622 17.5%
2016 80.384.031 19.9%
2017 85.060.509 5.5%
2018 85.295.427 0.28%
2019 91.886.775 7.17%
2020 105.927.166 13.25%
2021 134.877.000 21.46%
2022 169.502.000 20.43%
2023 201.566.000 15.91%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

cBrain A/S Assets
Year Assets Growth
2005 8.984.269
2006 22.169.379 59.47%
2007 27.312.690 18.83%
2008 27.320.919 0.03%
2009 33.656.092 18.82%
2010 36.324.244 7.35%
2011 44.758.565 18.84%
2012 49.240.058 9.1%
2013 55.652.637 11.52%
2014 68.315.605 18.54%
2015 84.877.145 19.51%
2016 98.978.128 14.25%
2017 102.604.315 3.53%
2018 104.578.427 1.89%
2019 121.025.727 13.59%
2020 155.100.257 21.97%
2021 215.851.000 28.14%
2022 322.693.000 33.11%
2023 364.879.000 11.56%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

cBrain A/S Liabilities
Year Liabilities Growth
2005 6.596.137
2006 4.771.665 -38.24%
2007 7.098.612 32.78%
2008 3.859.846 -83.91%
2009 5.249.370 26.47%
2010 5.811.646 9.67%
2011 7.581.897 23.35%
2012 8.920.687 15.01%
2013 10.457.290 14.69%
2014 15.189.554 31.15%
2015 20.485.523 25.85%
2016 18.594.097 -10.17%
2017 17.543.806 -5.99%
2018 19.283.000 9.02%
2019 29.138.952 33.82%
2020 49.173.091 40.74%
2021 80.974.000 39.27%
2022 153.191.000 47.14%
2023 163.313.000 6.2%

cBrain A/S Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
9.61
Net Income per Share
1.96
Price to Earning Ratio
110.33x
Price To Sales Ratio
22.53x
POCF Ratio
67.96
PFCF Ratio
-25.8
Price to Book Ratio
24.98
EV to Sales
23.05
EV Over EBITDA
63.12
EV to Operating CashFlow
69.5
EV to FreeCashFlow
-26.39
Earnings Yield
0.01
FreeCashFlow Yield
-0.04
Market Cap
4,23 Bil.
Enterprise Value
4,33 Bil.
Graham Number
19.56
Graham NetNet
-7.72

Income Statement Metrics

Net Income per Share
1.96
Income Quality
1.26
ROE
0.25
Return On Assets
0.3
Return On Capital Employed
0.47
Net Income per EBT
0.78
EBT Per Ebit
0.96
Ebit per Revenue
0.34
Effective Tax Rate
0.22

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.45
Operating Profit Margin
0.34
Pretax Profit Margin
0.33
Net Profit Margin
0.25

Dividends

Dividend Yield
0
Dividend Yield %
0.1
Payout Ratio
0.09
Dividend Per Share
0.21

Operating Metrics

Operating Cashflow per Share
3.19
Free CashFlow per Share
-8.39
Capex to Operating CashFlow
-3.63
Capex to Revenue
-1.2
Capex to Depreciation
-12.01
Return on Invested Capital
0.14
Return on Tangible Assets
0.14
Days Sales Outstanding
0
Days Payables Outstanding
-99.55
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
-3.67
Inventory Turnover
0
Capex per Share
-11.58

Balance Sheet

Cash per Share
0,11
Book Value per Share
8,67
Tangible Book Value per Share
5.85
Shareholders Equity per Share
8.67
Interest Debt per Share
5.08
Debt to Equity
0.58
Debt to Assets
0.31
Net Debt to EBITDA
1.4
Current Ratio
1.02
Tangible Asset Value
0,11 Bil.
Net Current Asset Value
-0,10 Bil.
Invested Capital
0.58
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.17
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

cBrain A/S Dividends
Year Dividends Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

cBrain A/S Profile

About cBrain A/S

cBrain A/S, a software company, develops and provides software solutions for government, private, education, and non-profit sectors in Denmark and internationally. The company offers F2 Digital Platform, an integrated software solution that combines case management, process management, and knowledge management, including full support for specialized government routines and compliance. It also provides F2 platform for automation of the public administration; and Government Climate Software. The company was founded in 2002 and is headquartered in Copenhagen, Denmark.

CEO
Mr. Per Tejs Knudsen
Employee
167
Address
Kalkbrænderiløbskaj 2
Copenhagen, 2100

cBrain A/S Executives & BODs

cBrain A/S Executives & BODs
# Name Age
1 Mr. Per Tejs Knudsen
Founder, Chief Executive Officer & Director
70
2 Mr. Thomas Qvist
Chief Technology Officer & Director
70
3 Mr. Tony Summerlin
Chief Executive Officer of cBrain North America
70
4 Mr. Ejvind Jørgensen
Chief Financial Officer & Head of Investor Relations
70
5 Mr. Robert Lentz
Chief Operating Officer
70

cBrain A/S Competitors

ChemoMetec A/S Logo
ChemoMetec A/S

CHEMM.CO

(2.0)
Ambu A/S Logo
Ambu A/S

AMBU-B.CO

(0.5)
Genmab A/S Logo
Genmab A/S

GMAB.CO

(2.2)
Zealand Pharma A/S Logo
Zealand Pharma A/S

ZEAL.CO

(0.5)
Netcompany Group A/S Logo
Netcompany Group A/S

NETC.CO

(2.2)